References
- Halpérin D, Wacker P, Lacomt G. Effects of recombinant erythropoietin in infants with anemia of prematurity: a pilot study. J Pedialr. 1990; 116: 779–780
- Shannon K M, Mentzer W C, Abels R I. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. J Pediatr. 1991; 118: 949–955
- Obladen M, Maier R, Segerer H. Efficacy and safety of recombinant human erythropoietin to prevent the anemia of prematurity. Erythropoietin in Renal and Non-Renal Anemias, HJ Guriand, J Moran, W Samtleben, P Scigalla, L Wieczorek. Karger, Basel 1991; 314–326, Contrib Nephrol 88
- Ohls R, Christensen R. Recombinant erythropoietin compare with erythrocite transfusion in the treatment of the anemia of prematurity. J Pediatr. 1991; 119: 781–788
- Shannon K M, Mentzer W C, Abels R I. Enhancement of erythropoiesis by recombinant erythropoietin in low birth weight infants: a pilot study. J Pediatr. 1992; 120: 586–592
- Carnielli V, Montini G, Da Riol R, Dall'Amico R, Cantarutti F. Effects of high doses of human recombinant erythropoietin on the need for blood transfusions in the preterm infants. J Pediatr. 1992; 121: 98–102
- Emmerson A, Coles H, Stern C, Pearson T. Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child. 1993; 63: 291–296
- Messer J, Haddad J, Donato I, Astruc D, Matis J. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1992; 92: 519–523
- Bechensteen A G, Haya P, Halvorsen S. Erythropoietin, protein, and iron supplementation and the prevention of anemia of prematurity. Arch Dis Child. 1993; 69: 19–23
- Soubasi V, Kremenopoulos G, Diamandi E, Tsantali C, Tsakiris D. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized controlled study. Pediatr Res. 1993; 34: 675–679
- Halperin D, Felix M, Wacker P, Lacourt G, Babel J, Wyss M. Recombinant human erythropoietin in the treatment of infants with anemia of prematurity. Eur J Pediatr. 1992; 151: 661–667
- Maier R F, Obladen M, Scigalla P. The effect of epoietin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med. 1994; 330: 1173–1178
- Meyer M P, Meyer J H, Commerford A. Recombinant human erythropoietin in treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics 1994; 93: 918–923
- Obladen M, Sachsenwenger M, Stahkne M. Blood sampling in VLBW infants receiving different levels of intensive care. Eur J Pediatr. 1988; 147: 399–404
- Sabio H. Anaemia in the high risk infant. Clin Perinatol. 1984; 11: 59–72
- Nexo E, Christensen N C, Olesen H. Volume of blood removed for analytical purposes during hospitalisation of VLBW infants. Clin Chem. 1981; 27: 759–761
- Halpérin D. Use of recombinant erythropoietin in treatment of the anemia of prematurity. Am J Pediatr Hematol Oncol. 1991; 13: 351–363
- Brown M S, Berman E R, Luckey D. Prediction of the need for transfusion during anaemia of prematurity. J Pediatr. 1990; 116: 773–778
- Wood A, Wilson N, Skacel P, Thomas R, Tidmarsh E Yale C. Reducing donor exposure in preterm infants requiring multiple blood transfusions. Arch Dis Child. 1995; 72: F29–F33
- Williamson P, Griffiths G, Worfolk D, Levene M. Blood transfusions and human recombinant erythropoietin in premature newborn infants. Arch Dis Child. 1996; 75: 65–68